arrow
I

Ingrid Prytz Berset

More og Romsdal Hospital Trust
H指数:12
被引数:1,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal transcriptomic analysis of mucosa in ulcerative colitis after anti-tumor necrosis factor withdrawal compared to continued treatment

与持续治疗相比,溃疡性结肠炎黏膜在抗肿瘤坏死因子撤药后的纵向转录组学分析

2026-08-120
OAAI
Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial

抗肿瘤坏死因子撤药或长期治疗在溃疡性结肠炎中的应用(BIOSTOP):一项多中心开放标签随机对照试验

2026-08-060
PRE
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
2020-09-2318
OAAI
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
2019-04-1290
OAAI
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease

欧洲克罗恩病和结肠炎组织对炎症性肠病的治疗退出 [“退出策略”] 进行专题审查

2017-08-02143
OAAI